Health Velocity Capital
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- USA
Investment stages
- Seed
Industries
- Health Tech
- Consumer Products
- Pharma
- Medical Devices
- Digital Health
About
Health Velocity Capital is a leading venture capital and private equity firm dedicated to transforming the healthcare landscape through strategic investments in innovative software and service companies. By identifying and supporting groundbreaking solutions, Health Velocity Capital aims to enhance accessibility, affordability, and overall consumer experience in healthcare. The firm leverages its extensive industry expertise and network to empower portfolio companies, driving sustainable growth and fostering advancements that contribute to a more efficient and patient-centric healthcare system. Through its commitment to innovation, Health Velocity Capital strives to shape a healthier future for individuals and communities alike.
Health Velocity Capital is a leading venture capital and private equity firm dedicated to transforming the healthcare landscape through strategic investments in innovative software and service companies. By identifying and supporting groundbreaking solutions, Health Velocity Capital aims to enhance accessibility, affordability, and overall consumer experience in healthcare. The firm leverages its extensive industry expertise and network to empower portfolio companies, driving sustainable growth and fostering advancements that contribute to a more efficient and patient-centric healthcare system. Through its commitment to innovation, Health Velocity Capital strives to shape a healthier future for individuals and communities alike.
Investment Thesis
They invest exclusively in innovative healthcare software and services businesses to create a more affordable, sustainable, consumerfriendly future.
Manager's Experience
With a strong foundation in healthcare investments, the fund manager boasts extensive experience across various sectors, including biotechnology, medical devices, and healthcare services. The strategy emphasizes a data-driven approach, facilitating informed decision-making throughout the investment lifecycle. Demonstrating a robust track record, they have executed over 30 deals, successfully navigating the complexities of early-stage and growth investments. Notable exits highlight their expertise in identifying high-potential opportunities, particularly in North America and Europe, showcasing a commitment to fostering innovation within the healthcare landscape.
Team
Bruce Crosby
Martin Felsenthal
Julie Foster